BD to separate Biosciences and Diagnostic Solutions Business
BD's board approves separation plan to enhance strategic focus and growth-oriented investments and capital allocation for both BD and the separated business
BD's board approves separation plan to enhance strategic focus and growth-oriented investments and capital allocation for both BD and the separated business
Eppendorf Tubes ® BioBased are a new era of laboratory tubes made with bio-based, eco-friendly polymer that doesn’t sacrifice quality or performance.

RNase Block Ribonuclease Inhibitor is a 50-kDa protein that specifically inhibits common eukaryotic RNases including RNase A, RNase B, and RNase C.
Specially treated Human Serum Albumin, optimized for human ES and iPS cell culture. Designed for optimal cryopreservation of hMSCs
The system’s unique technology utilizes microfluidics and live imaging to monitor bacterial growth across a linear antibiotic gradient
In this guest editorial, Pascal Steffen-Lockhauserbäumer, Global Product Manager for timsTOF at Bruker Daltonics explores how spatial multiomics combines imaging with LC/MS to revolutionize biomolecular analysis, enabling high-resolution insights into disease mechanisms, immune response, and tissue structure, with applications in diagnostics and personalized medicine
Cell imaging plays a vital role in the analysis of cellular systems, offering valuable insights into various aspects of cell health, behavior, and structure. It enables researchers to understand fundamental cellular processes, monitor changes in response to treatments, investigate structural alterations, and gather data on both individual cells and populations.
Recognition underscores Bruker’s commitment to sustainability and innovation in microbial detection
Bridging the gap between PCR and next-generation sequencing technologies, the Countable 10 is the first PCR instrument to analyze 10 distinct fluorophores in the same reaction
Research at Karl Landsteiner University of Health Sciences offers new insight in brain connectivity and development
Resolian has established itself as a world-class leader in biopharmaceutical drug development through analytical excellence with over 500 scientists across three global labs.
Contrasting membrane for microbiological analysis
Key topics included the health effects of plastics, tackling medical misinformation, and advancing clinical care with AI
Explore innovations and tools for clinical labs shaping the future of sepsis management, clinical mass spec, anticoagulant diagnostics, and more